Macquarie Group
NPTN

Macquarie Group’s NEOPHOTONICS CORP NPTN Stock Holding History

Macquarie Group’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-615
Closed -$10K – 2569
2022
Q2 		$10K Hold
615
– – ﹤0.01% 2451
2022
Q1 		$9 Hold
615
– – ﹤0.01% 2533
2021
Q4 		$9K Sell
615
-5,466
-90% -$71.9K ﹤0.01% 2530
2021
Q3 		$53K Buy
6,081
+5,462
+882% +$49.8K ﹤0.01% 2219
2021
Q2 		$6K Buy
+619
New +$6.54K ﹤0.01% 2523
2020
Q4 		– Sell
-9,647
Closed -$59K – 2388
2020
Q3 		$59K Buy
+9,647
New +$73.6K ﹤0.01% 1923
2019
Q1 		– Sell
-5,200
Closed -$34K – 2172
2018
Q4 		$34K Buy
+5,200
New +$39.8K ﹤0.01% 1673

Other funds holding NPTN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Macquarie Group's NPTN Position: Q3 2022 in Review

Macquarie Group sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 615 shares — an estimated $10K sold.

Macquarie Group first reported a position in NPTN in Q4 2018 and held it in 7 quarters. The position peaked at $59K in Q3 2020. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Macquarie Group reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 615 NEOPHOTONICS CORP shares in Q3 2022, an estimated $10K.
  • Macquarie Group first reported a position in NEOPHOTONICS CORP in Q4 2018 and held it in 7 quarters.
  • Macquarie Group's NEOPHOTONICS CORP position peaked at $59K in Q3 2020.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.